Related Experiment Video
Updated: May 20, 2026

06:14
Induction of Periodontitis via a Combination of Ligature and Lipopolysaccharide Injection in a Rat Model
Published on: February 17, 2023
Localized reduction of gingival inflammation using site-specific therapy with a topical gingival patch
Noah Samuels1, Aron Saffer, Isaiah D Wexler
1Center for Integrative Complementary Medicine, Shaare Zedek Medical Center, Jerusalem, Israel. refplus@netvision.net.il
Summary
A novel topical gingival patch significantly reduced inflammation in patients with chronic periodontitis by decreasing neutrophilic activity. This pilot study suggests the patch is a promising new treatment for gingival inflammation.
Area of Science:
- Periodontology
- Oral Inflammation
- Biomaterials
Background:
- Chronic periodontitis is characterized by gingival inflammation.
- Current treatments like scaling and root planing are effective but invasive.
- Novel topical treatments are needed to manage gingival inflammation.
Purpose of the Study:
- To evaluate the efficacy of a novel topical gingival patch in reducing gingival inflammation.
- To assess the impact of the patch on neutrophilic activity and clinical signs of inflammation.
Main Methods:
- A pilot study involving 26 patients with moderate-to-severe chronic periodontitis.
- Gingival inflammation sites were treated with a topical patch or left as untreated controls for 24 hours.
- Inflammation was measured by gingival crevicular fluid (GCF) beta-glucuronidase (b-glu) levels and the gingival index (GI).
Main Results:
- Patch placement significantly reduced GCF b-glu levels compared to controls (p = 0.002), with a 29.7% reduction from baseline.
- Untreated control sites showed an increase in mean b-glu levels and percent change from baseline.
- The gingival index (GI) response rate was also better in the patch-treated group (p = 0.053).
- No adverse events were reported.
Conclusions:
- The topical gingival patch demonstrated a reduction in gingival inflammation.
- This novel treatment warrants further clinical investigation for managing gingival inflammation.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

